Guideline Video

Guideline Resources

  • Early Detection of Oral Squamous Cell Carcinoma and Potentially Malignant Disorders
  • American Dental Association
  • March 3, 2026
  • Summary
  • Full-text

Video Transcription

Just published March 3rd, 2026, the American Dental Association’s newest guideline on Early Detection of Oral Squamous Cell Carcinoma and Potentially Malignant Disorders.

This guideline addresses the use of cytology adjuncts to screen adults without mucosal abnormalities and determine the need for biopsy among adults with mucosal abnormalities.

In today’s rapid update, we’ll be going over the recommendations and good practice statements. For the full guideline, make sure to check it out on guidelinecentral.com

There were 3 recommendations and 3 good practice statements. Let’s get started. 

Starting with the recommendations, 

  • The guideline panel suggests against the use of cytology adjuncts to determine the need for biopsy or a referral among adult patients with any mucosal abnormality in the oral cavity or on the lip.
  • If biopsy of a mucosal abnormality in the oral cavity or on the lip is not possible, advisable, or indicated, the guideline panel suggests that clinicians offer a cytology adjunct to adult patients to further inform the need for biopsy. This is particularly relevant for mucosal abnormalities that manifest as clinically worrisome.
  • The guideline panel suggests against the use of cytology adjuncts to screen for the potential need for biopsy or a referral among asymptomatic adult patients with no clinically evident oral mucosal abnormality in the oral cavity or on the lip.

Then for the good practice statements, 

  • Clinicians should obtain from all adult patients an updated medical, social, and dental history and perform a clinical oral examination, including both an extraoral and intraoral examination.
  • Clinicians should explain to all adult patients the importance and purpose of the clinical oral examination, which includes early detection of mucosal abnormalities such as oral potentially malignant disorder and oral cavity cancer.
  • If the clinician detects persistence or progression of the mucosal abnormality in the oral cavity or on the lip despite a negative cytology test result, they should perform a biopsy or refer the patient to a specialist.

And there you have it. Make sure to check out the full guideline from the American Dental Association and other related clinical decision support tools at guidelinecentral.com.

Sign up for alerts and stay informed on the latest published articles and guidelines.